Length of Tumour Feeding Artery After Colon Cancer Surgery

Overview

The quality of colon cancer surgery is highly debated these years since the mortality of the disease is not declining markedly. Surgery is the main treatment of colon cancer and during surgery it is very important for the surgeon to remove the tumour and all potential ways of tumour spread. As colon cancer first of all spreads to the nearby lymph nodes lying along the tumour feeding artery the surgeon aims to cut the vessel as central as possible. This means that all of the tumour feeding artery should have been removed after surgery. In this study the investigators want to measure the length of the tumour feeding artery after surgery as a quality control of the surgery. The investigators hypothesize that the artery will be shorter than 5 mm. The investigators wish to CT scan all patients two days after colon cancer surgery and afterwards measure then length of the artery on the images. This study will not inflict with the normal routine for patient information and treatment.

Study Type

  • Study Type: Observational
  • Study Design
    • Time Perspective: Prospective
  • Study Primary Completion Date: November 2014

Interventions

  • Other: Patients with primary colon cancer
    • CT scan two days after surgery

Arms, Groups and Cohorts

  • Quality of colon cancer surgery
    • Patients with primary colon cancer

Clinical Trial Outcome Measures

Primary Measures

  • CT scan after colon cancer surgery. The length of the tumour feeding artery will be measured on the images.
    • Time Frame: 6 to 9 months
    • Patients will have an extra CT scan two days after surgery.

Participating in This Clinical Trial

Inclusion Criteria

  • Primary colon cancer Exclusion Criteria:

  • Kidney failure, allergy to contrast, pregnancy

Gender Eligibility: All

Minimum Age: 18 Years

Maximum Age: N/A

Are Healthy Volunteers Accepted: No

Investigator Details

  • Lead Sponsor
    • University of Aarhus
  • Provider of Information About this Clinical Study
    • Sponsor
  • Overall Official(s)
    • Soren Laurberg, Professor, Study Director, Aarhus University Hospital
  • Overall Contact(s)
    • Ditte Munkedal, MD, +45 7846 7710, Ditte.Munkedal@viborg.rm.dk

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.